REPLIGEN CORP — Director's Dealing 2014

Nov 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-11-11

Reporting Person: Benjamin Howard (VP Business Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-11	Common Stock	S	30000	$23.56	Disposed	43851	Direct

Footnotes

F1: $23.56 is a weighted average price. These shares were sold in multiple transactions at the prices ranging from $23.10 to $23.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within range.